Sun Yat-sen University Cancer Center

Guangdong 510060

3 studies enrolling now · 5 studies all time

What they study most

Chronic Lymphocytic Leukemia, Locally Advanced or Unresectable Metastatic Breast Cancer, Lymphoma, Small Lymphocytic, Metastatic Breast Cancer, Neoplasm Metastasis, Platinum-resistant Ovarian Cancer, Stage IV Breast Cancer, Ureteral Neoplasms, Urinary Bladder Neoplasms

Studies at this site

• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed